Guggenheim Capital’s LeMaitre Vascular LMAT Stock Holding History

Guggenheim Capital’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-5,612	Closed	-$227K	–	2156
2020 Q4	$227K	Buy	+5,612	New	+$201K	﹤0.01%	1914
2018 Q4	–	Sell	-16,336	Closed	-$633K	–	2279
2018 Q3	$633K	Buy	16,336 +3,071	+23%	+$111K	﹤0.01%	1853
2018 Q2	$445K	Sell	13,265 -51,288	-79%	-$1.82M	﹤0.01%	2012
2018 Q1	$2.34M	Buy	64,553 +499	+0.8%	+$17.3K	0.01%	1522
2017 Q4	$2.04M	Buy	64,054 +9,034	+16%	+$309K	﹤0.01%	1652
2017 Q3	$2.06M	Sell	55,020 -260	-0.5%	-$8.85K	﹤0.01%	1637
2017 Q2	$1.72M	Buy	+55,280	New	+$1.6M	﹤0.01%	1737

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

SCA

Summit Creek Advisors Minneapolis, Minnesota $487M AUM 11.23% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Guggenheim Capital's LMAT Position: Q1 2021 in Review

Guggenheim Capital sold out of LeMaitre Vascular (LMAT) in Q1 2021, closing a stake of 5,612 shares — an estimated $227K sold.

Guggenheim Capital first reported a position in LMAT in Q2 2017 and held it in 7 quarters. The position peaked at $2.34M in Q1 2018. 179 funds tracked by Wall St. Rank hold LMAT as of Q1 2021.

Guggenheim Capital reported no remaining LeMaitre Vascular position as of Q1 2021 after selling out during the quarter.
Guggenheim Capital sold 5,612 LeMaitre Vascular shares in Q1 2021, an estimated $227K.
Guggenheim Capital first reported a position in LeMaitre Vascular in Q2 2017 and held it in 7 quarters.
Guggenheim Capital's LeMaitre Vascular position peaked at $2.34M in Q1 2018.
179 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2021.

Based on Guggenheim Capital's 13F filing for Q1 2021, filed 13 May 2021.